• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟代过氧化物酶体增殖物激活受体 α/γ 双重激动剂的合成、生物评价及分子研究。

Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors α/γ dual agonists.

机构信息

Dipartimento Farmaco-Chimico, Università degli Studi di Bari 'Aldo Moro', Via Orabona 4, 70126 Bari, Italy.

出版信息

Bioorg Med Chem. 2012 Mar 15;20(6):2141-51. doi: 10.1016/j.bmc.2012.01.025. Epub 2012 Jan 28.

DOI:10.1016/j.bmc.2012.01.025
PMID:22341573
Abstract

PPARs are transcription factors that govern lipid and glucose homeostasis and play a central role in cardiovascular disease, obesity, and diabetes. Thus, there is significant interest in developing new agonists for these receptors. Given that the introduction of fluorine generally has a profound effect on the physical and/or biological properties of the target molecule, we synthesized a series of fluorinated analogs of the previously reported compound 2, some of which turned out to be remarkable PPARα and PPARγ dual agonists. Docking experiments were also carried out to gain insight into the interactions of the most active derivatives with both receptors.

摘要

过氧化物酶体增殖物激活受体(PPARs)是调节脂质和葡萄糖稳态的转录因子,在心血管疾病、肥胖症和糖尿病中发挥着核心作用。因此,人们对开发这些受体的新型激动剂有着浓厚的兴趣。鉴于氟原子的引入通常会对靶分子的物理和/或生物学性质产生深远的影响,我们合成了一系列先前报道的化合物 2 的氟化类似物,其中一些化合物被证明是显著的 PPARα 和 PPARγ 双重激动剂。还进行了对接实验,以深入了解最活跃的衍生物与两种受体的相互作用。

相似文献

1
Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors α/γ dual agonists.氟代过氧化物酶体增殖物激活受体 α/γ 双重激动剂的合成、生物评价及分子研究。
Bioorg Med Chem. 2012 Mar 15;20(6):2141-51. doi: 10.1016/j.bmc.2012.01.025. Epub 2012 Jan 28.
2
Synthesis, biological evaluation, and molecular modeling investigation of chiral phenoxyacetic acid analogues with PPARalpha and PPARgamma agonist activity.具有PPARα和PPARγ激动剂活性的手性苯氧基乙酸类似物的合成、生物学评价及分子模拟研究
ChemMedChem. 2007 May;2(5):641-54. doi: 10.1002/cmdc.200600307.
3
Synthesis, biological evaluation, and molecular modeling investigation of new chiral fibrates with PPARalpha and PPARgamma agonist activity.具有PPARα和PPARγ激动剂活性的新型手性贝特类药物的合成、生物学评价及分子模拟研究
J Med Chem. 2005 Aug 25;48(17):5509-19. doi: 10.1021/jm0502844.
4
Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors α/γ agonists.核受体选择性的分子决定因素:过氧化物酶体增殖物激活受体α/γ双重激动剂的化学计量分析、对接和定点突变。
Eur J Med Chem. 2013 May;63:321-32. doi: 10.1016/j.ejmech.2013.02.015. Epub 2013 Feb 24.
5
Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?鱼油中的ω-3长链脂肪酸及其衍生物是过氧化物酶体增殖物激活受体激动剂吗?
Cardiovasc Diabetol. 2008 Mar 20;7:6. doi: 10.1186/1475-2840-7-6.
6
New 2-aryloxy-3-phenyl-propanoic acids as peroxisome proliferator-activated receptors alpha/gamma dual agonists with improved potency and reduced adverse effects on skeletal muscle function.新型2-芳氧基-3-苯基丙酸作为过氧化物酶体增殖物激活受体α/γ双重激动剂,具有更高的效力和对骨骼肌功能更低的不良反应。
J Med Chem. 2009 Oct 22;52(20):6382-93. doi: 10.1021/jm900941b.
7
Design, synthesis, and structure-activity relationships of piperidine and dehydropiperidine carboxylic acids as novel, potent dual PPARalpha/gamma agonists.作为新型强效双PPARα/γ激动剂的哌啶和脱氢哌啶羧酸的设计、合成及构效关系
Bioorg Med Chem Lett. 2008 Jun 15;18(12):3545-50. doi: 10.1016/j.bmcl.2008.05.014. Epub 2008 May 6.
8
Design and synthesis of benzoxazole containing indole analogs as peroxisome proliferator-activated receptor-γ/δ dual agonists.设计并合成含苯并恶唑基吲哚类似物作为过氧化物酶体增殖物激活受体-γ/δ双重激动剂。
Bioorg Med Chem Lett. 2011 May 15;21(10):3057-61. doi: 10.1016/j.bmcl.2011.03.027. Epub 2011 Mar 24.
9
Synthesis, biological evaluation, and molecular modeling investigation of chiral 2-(4-chloro-phenoxy)-3-phenyl-propanoic acid derivatives with PPARalpha and PPARgamma agonist activity.具有PPARα和PPARγ激动剂活性的手性2-(4-氯苯氧基)-3-苯基丙酸衍生物的合成、生物学评价及分子模拟研究
Bioorg Med Chem. 2008 Nov 1;16(21):9498-510. doi: 10.1016/j.bmc.2008.09.045. Epub 2008 Sep 19.
10
Peroxisome proliferator-activated receptors (PPARs) have multiple binding points that accommodate ligands in various conformations: phenylpropanoic acid-type PPAR ligands bind to PPAR in different conformations, depending on the subtype.过氧化物酶体增殖物激活受体(PPARs)具有多个结合点,可以容纳各种构象的配体:苯丙酸型 PPAR 配体根据亚型与 PPAR 以不同构象结合。
J Med Chem. 2012 Jan 26;55(2):893-902. doi: 10.1021/jm2014293. Epub 2012 Jan 10.

引用本文的文献

1
Cladosporols and PPARγ: Same Gun, Same Bullet, More Targets.枝孢菌素和过氧化物酶体增殖物激活受体 γ:同一把枪,同样的子弹,更多的目标。
Biomolecules. 2024 Aug 13;14(8):998. doi: 10.3390/biom14080998.
2
Biological Screening and Crystallographic Studies of Hydroxy γ-Lactone Derivatives to Investigate PPARγ Phosphorylation Inhibition.羟基 γ-内酯衍生物的生物筛选和晶体学研究,以研究 PPARγ 磷酸化抑制。
Biomolecules. 2023 Apr 19;13(4):694. doi: 10.3390/biom13040694.
3
Structural Biology-Based Exploration of Subtype-Selective Agonists for Peroxisome Proliferator-Activated Receptors.
基于结构生物学的过氧化物酶体增殖物激活受体亚型选择性激动剂研究
Int J Mol Sci. 2021 Aug 26;22(17):9223. doi: 10.3390/ijms22179223.
4
Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases.用于预防和治疗心血管疾病及神经退行性疾病的天然化合物
Foods. 2020 Dec 24;10(1):29. doi: 10.3390/foods10010029.
5
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors.超越经典内源性大麻素系统。过氧化物酶体增殖物激活受体配体作为 FAAH 抑制剂的筛选。
Int J Mol Sci. 2020 Sep 24;21(19):7026. doi: 10.3390/ijms21197026.
6
Chiral phenoxyacetic acid analogues inhibit colon cancer cell proliferation acting as PPARγ partial agonists.手性苯氧乙酸类似物作为 PPARγ 部分激动剂抑制结肠癌细胞增殖。
Sci Rep. 2019 Apr 1;9(1):5434. doi: 10.1038/s41598-019-41765-2.
7
An innovative approach for the treatment of Alzheimer's disease: the role of peroxisome proliferator-activated receptors and their ligands in development of alternative therapeutic interventions.一种治疗阿尔茨海默病的创新方法:过氧化物酶体增殖物激活受体及其配体在开发替代治疗干预措施中的作用
Neural Regen Res. 2019 Jan;14(1):43-45. doi: 10.4103/1673-5374.241043.
8
Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer's Disease.具有多靶点活性的天然支架用于阿尔茨海默病的潜在治疗。
Molecules. 2018 Aug 29;23(9):2182. doi: 10.3390/molecules23092182.
9
Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer's disease therapy.杂环化合物作为阿尔茨海默病治疗中与新旧靶点相互作用的关键结构。
Neural Regen Res. 2017 Aug;12(8):1256-1261. doi: 10.4103/1673-5374.213541.
10
New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge.阿尔茨海默病预防与治疗的新方法:一项引人入胜的挑战。
Neural Regen Res. 2017 Mar;12(3):405-406. doi: 10.4103/1673-5374.202942.